BioVentrix Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Latest Deal Amount
  • $17M

  • Investors
  • 8

BioVentrix General Information

Description

Developer of surgical equipment designed to improve and expand the treatment for congestive heart failure. The company's equipment improves cardiac function by restoring the size, volume and resulting function of the left ventricle in heart failure patients caused by ischemic cardiomyopathy, enabling physicians to be provided with innovative technology that corrects the anatomical damage created by congestive heart failure to slow the progression of this debilitating and fatal disease.

Contact Information

Website
bioventrix.com
Formerly Known As
CHF Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 120 Forbes Boulevard
  • Suite 125
  • Mansfield, MA 02048
  • United States
+1 (925)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Corporate Office
  • 120 Forbes Boulevard
  • Suite 125
  • Mansfield, MA 02048
  • United States
+1 (925)

BioVentrix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioVentrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
19. IPO 14-Oct-2026 $17M Cancelled Generating Revenue/Not Profitable
18. Later Stage VC 29-Mar-2024 Completed Generating Revenue
17. Later Stage VC (Series A) 03-Apr-2023 Completed Generating Revenue
16. Later Stage VC 05-Apr-2022 Completed Generating Revenue
15. Later Stage VC 10-Jan-2022 Completed Generating Revenue
14. Later Stage VC 25-Nov-2020 Completed Generating Revenue
13. Debt - PPP 14-Apr-2020 Completed Generating Revenue
12. Later Stage VC (Series A1) 23-Jul-2019 Completed Generating Revenue
11. Later Stage VC 30-Jun-2017 $14.5M $97.2M Completed Generating Revenue
10. Later Stage VC (Series A) 08-Dec-2015 $14M $82.7M Completed Generating Revenue
To view BioVentrix’s complete valuation and funding history, request access »

BioVentrix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view BioVentrix’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BioVentrix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of surgical equipment designed to improve and expand the treatment for congestive heart failure. The company's
Surgical Devices
Mansfield, MA
7 As of 2026

Kirkland, WA
 

Clichy, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioVentrix Competitors (9)

One of BioVentrix’s 9 competitors is Cardiac Dimensions, a Venture Capital-Backed company based in Kirkland, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardiac Dimensions Venture Capital-Backed Kirkland, WA
CorWave Venture Capital-Backed Clichy, France
HighLife Venture Capital-Backed Paris, France
Foldax Venture Capital-Backed Salt Lake City, UT
Atricure Formerly VC-backed Mason, OH
You’re viewing 5 of 9 competitors. Get the full list »

BioVentrix Patents

BioVentrix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4416740-A1 Device and methods for monitoring heart function for treatment of congestive heart failure and other conditions Pending 15-Oct-2021
US-20250005759-A1 Device and methods for monitoring heart function for treatment of congestive heart failure and other conditions Pending 15-Oct-2021
WO-2023064525-A1 Device and methods for monitoring heart function for treatment of congestive heart failure and other conditions Inactive 15-Oct-2021
EP-4216828-B1 Pericardial inflation catheter and systems Active 24-Sep-2020
EP-4216828-A1 Pericardial inflation catheter and systems and methods employing same Active 24-Sep-2020 A61B17/3478
To view BioVentrix’s complete patent history, request access »

BioVentrix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioVentrix Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cormorant Asset Management PE/Buyout Minority
Squarepoint Capital Hedge Fund Minority
Angel (individual) Minority
Psilos Group Managers Venture Capital Minority
Double D Venture Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

BioVentrix Acquisitions (1)

BioVentrix’s most recent deal was a Merger/Acquisition with MateraCor. The deal was made on 27-Jan-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MateraCor 27-Jan-2022 Merger/Acquisition Therapeutic Devices
To view BioVentrix’s complete acquisitions history, request access »

BioVentrix FAQs

  • When was BioVentrix founded?

    BioVentrix was founded in 2003.

  • Where is BioVentrix headquartered?

    BioVentrix is headquartered in Mansfield, MA.

  • What is the size of BioVentrix?

    BioVentrix has 7 total employees.

  • What industry is BioVentrix in?

    BioVentrix’s primary industry is Surgical Devices.

  • Is BioVentrix a private or public company?

    BioVentrix is a Private company.

  • What is BioVentrix’s current revenue?

    The current revenue for BioVentrix is .

  • How much funding has BioVentrix raised over time?

    BioVentrix has raised $214M.

  • Who are BioVentrix’s investors?

    Cormorant Asset Management, Squarepoint Capital, , Psilos Group Managers, and Double D Venture are 5 of 8 investors who have invested in BioVentrix.

  • Who are BioVentrix’s competitors?

    Cardiac Dimensions, CorWave, HighLife, Foldax, and Atricure are some of the 9 competitors of BioVentrix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process